Physician profile
Michelle L Baechle
NPI 1649578535
$3,808.93
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $485 · 2023: $901 · 2024: $1,810 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Education: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Education | $469.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $952.60 | 2024 | Opzelura |
| Abbvie INC. | $572.98 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $480.90 | 2023-2025 | Sotyktu |
| Janssen Biotech, INC. | $403.75 | 2021-2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $370.96 | 2021-2024 | Dupixent |
| Pfizer INC. | $369.74 | 2021-2025 | |
| Genzyme Corporation | $142.72 | 2022-2024 | |
| Lilly USA, LLC | $115.72 | 2021-2024 | Taltz, Olumiant |
| Dermavant Sciences, INC. | $82.51 | 2023 | Vtama |
| Novartis Pharmaceuticals Corporation | $78.93 | 2021-2022 | |
| Amgen INC. | $70.48 | 2021-2022 | |
| Ucb, INC. | $55.88 | 2024 | Bimzelx |
| Galderma Laboratories, L.P. | $33.15 | 2022-2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $22.44 | 2025 | |
| Merz North America, INC. | $21.40 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $19.05 | 2024 | Zoryve |
| Almirall LLC | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Baechle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.